NVIDIA BioNeMo
Horizontal platform
Overview
NVIDIA BioNeMo Service is a cloud service for generative AI in drug discovery. It offers tools to quickly customize and deploy domain-specific, state-of-the-art biomolecular models at scale through cloud APIs. The platform supports protein structure prediction, molecular generation, and optimization, enabling researchers to accelerate drug discovery workflows using GPU-accelerated computing.
- Pricing model
- Usage-based
- Deployment
- SaaS (vendor-hosted), API / SDK
- Regions served
- Global
- Categories
- Language (LLM / NLP), Process automation, Biotechnology, API / SDK, Predictive / classical ML, Business intelligence, Usage-based, Horizontal platform, SaaS (vendor-hosted), Agentic / autonomous
- Last updated
- 4 October 2026
- Published
- 4 October 2026
Use cases
Deployment options
Data sources & provenance
Where this information came from, how it was checked and when it was last looked at. “Last updated” records a change to the record — it does not mean the record was verified.
- Data quality
- Data quality: Editorially Reviewed
- Primary source
- nvidia.com
- Sources cited
- 1
- Last reviewed
- 28 September 2026
- Last updated
- 4 October 2026
Spotted something out of date?
Anyone can suggest a correction — you don't need an account. An editor checks every suggestion against the sources before the record changes.